Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

December 24, 2021

Study Completion Date

January 15, 2022

Conditions

Healthy Subjects

Interventions

DRUG

NVP-2102

Tablet formulation for oral administration, single dose of NVP-2102 at Day 1

DRUG

NVP-2102-R

Tablet formulation for oral administration, single dose of NVP-2102-R at Day 1

Trial Locations (1)

H Plus Yangji Hospital, Seoul